Your Article Summary
See Latest ArticlesTargeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
Leukemia and Lymphoma, 07/02/09
Jayanthan A et al. - Drug combination studies using a panel of conventional and novel therapeutic agents show that ABT-737 potentiates the activity of agents that have inherent anti-lymphoma activity and provide support for the evaluation of ABT-737 in the clinical setting.
Related Articles
Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09
Relevance Score: 70%
Sperm quality before treatment in patients with early stage Hodgkin lymphoma enrolled in EORTC-GELA Lymphoma Group trials
Haematologica, 10/27/09
Relevance Score: 69%
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study : The Lancet Oncology
The Lancet Oncology - Online First, 10/12/09
Relevance Score: 69%
Hepatocellular carcinoma infiltrated with non-Hodgkins lymphoma: Report of a case
Surgery Today, 11/11/09
Relevance Score: 68%
Primary lymphoma of the colon
Saudi Journal of Gastroenterology, 10/05/09
Relevance Score: 68%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Maximizing Exercise in Breast Cancer Survivors
Clinical Journal of Oncology Nursing, 12/11/09
Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system
Pediatric Blood & Cancer, 12/11/09
Pancreatic tumors in children and adolescents: The Italian TREP project experience
Pediatric Blood & Cancer, 12/11/09